Lillehaug JR - Search Results

1

The protein acetyltransferase ARD1: a novel cancer drug target?

Arnesen T, Thompson PR, Varhaug JE, Lillehaug JR. Arnesen T, et al. Among authors: lillehaug jr. Curr Cancer Drug Targets. 2008 Nov;8(7):545-53. doi: 10.2174/156800908786241113. Curr Cancer Drug Targets. 2008. PMID: 18991565 Review.

2

Identification and characterization of the human ARD1-NATH protein acetyltransferase complex.

Arnesen T, Anderson D, Baldersheim C, Lanotte M, Varhaug JE, Lillehaug JR. Arnesen T, et al. Among authors: lillehaug jr. Biochem J. 2005 Mar 15;386(Pt 3):433-43. doi: 10.1042/BJ20041071. Biochem J. 2005. PMID: 15496142 Free PMC article.

3

Interaction between HIF-1 alpha (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1 alpha.

Arnesen T, Kong X, Evjenth R, Gromyko D, Varhaug JE, Lin Z, Sang N, Caro J, Lillehaug JR. Arnesen T, et al. Among authors: lillehaug jr. FEBS Lett. 2005 Nov 21;579(28):6428-32. doi: 10.1016/j.febslet.2005.10.036. Epub 2005 Nov 2. FEBS Lett. 2005. PMID: 16288748 Free PMC article.

4

Cloning and characterization of hNAT5/hSAN: an evolutionarily conserved component of the NatA protein N-alpha-acetyltransferase complex.

Arnesen T, Anderson D, Torsvik J, Halseth HB, Varhaug JE, Lillehaug JR. Arnesen T, et al. Among authors: lillehaug jr. Gene. 2006 Apr 26;371(2):291-5. doi: 10.1016/j.gene.2005.12.008. Epub 2006 Feb 28. Gene. 2006. PMID: 16507339

5

Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase.

Arnesen T, Betts MJ, Pendino F, Liberles DA, Anderson D, Caro J, Kong X, Varhaug JE, Lillehaug JR. Arnesen T, et al. Among authors: lillehaug jr. BMC Biochem. 2006 Apr 25;7:13. doi: 10.1186/1471-2091-7-13. BMC Biochem. 2006. PMID: 16638120 Free PMC article.

6

Identification of the human N(alpha)-acetyltransferase complex B (hNatB): a complex important for cell-cycle progression.

Starheim KK, Arnesen T, Gromyko D, Ryningen A, Varhaug JE, Lillehaug JR. Starheim KK, et al. Among authors: lillehaug jr. Biochem J. 2008 Oct 15;415(2):325-31. doi: 10.1042/BJ20080658. Biochem J. 2008. PMID: 18570629

7

Knockdown of human N alpha-terminal acetyltransferase complex C leads to p53-dependent apoptosis and aberrant human Arl8b localization.

Starheim KK, Gromyko D, Evjenth R, Ryningen A, Varhaug JE, Lillehaug JR, Arnesen T. Starheim KK, et al. Among authors: lillehaug jr. Mol Cell Biol. 2009 Jul;29(13):3569-81. doi: 10.1128/MCB.01909-08. Epub 2009 Apr 27. Mol Cell Biol. 2009. PMID: 19398576 Free PMC article.

8

A novel human NatA Nalpha-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1).

Arnesen T, Gromyko D, Kagabo D, Betts MJ, Starheim KK, Varhaug JE, Anderson D, Lillehaug JR. Arnesen T, et al. Among authors: lillehaug jr. BMC Biochem. 2009 May 29;10:15. doi: 10.1186/1471-2091-10-15. BMC Biochem. 2009. PMID: 19480662 Free PMC article.

9

Human Naa50p (Nat5/San) displays both protein N alpha- and N epsilon-acetyltransferase activity.

Evjenth R, Hole K, Karlsen OA, Ziegler M, Arnesen T, Lillehaug JR. Evjenth R, et al. Among authors: lillehaug jr. J Biol Chem. 2009 Nov 6;284(45):31122-9. doi: 10.1074/jbc.M109.001347. Epub 2009 Sep 10. J Biol Chem. 2009. PMID: 19744929 Free PMC article.

10

Depletion of the human Nα-terminal acetyltransferase A induces p53-dependent apoptosis and p53-independent growth inhibition.

Gromyko D, Arnesen T, Ryningen A, Varhaug JE, Lillehaug JR. Gromyko D, et al. Among authors: lillehaug jr. Int J Cancer. 2010 Dec 15;127(12):2777-89. doi: 10.1002/ijc.25275. Int J Cancer. 2010. PMID: 21351257

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters